Literature DB >> 3667710

Cytochemical and biochemical evidence of cathepsin B in malignant, transformed and normal breast epithelial cells.

E Krepela1, J Bártek, D Skalková, J Vicar, D Rasnick, J Taylor-Papadimitriou, R C Hallowes.   

Abstract

Human breast cancer cell lines, as well as transformed mammary epithelial cells (HBL-100) and growth-stimulated normal breast epithelial cells showed positive cytochemical reaction with the proteinase substrate 2-(N-benzyloxycarbonyl-L-arginyl-L-arginylamido)-4-methoxynapht halene, in the presence of 5-nitrosalicylaldehyde. The reaction product, small fluorescent granules, was distributed throughout the cytoplasm, in the perinuclear zone, in some cytoplasmic projections, and at the cell surface. Using a panel of various proteinase inhibitors, we found that the formation of the reaction product was an enzymic function of a cysteine proteinase. Using the substrate 7-(N-benzyloxycarbonyl-L-arginyl-L-arginylamido)-4-methylcoumarin, we evaluated some biochemical properties of the cysteine proteinase, including pH-activity profile, pH stability, apparent relative molecular mass and sensitivity toward various proteinase inhibitors. We found that the proteinase from the studied breast epithelial cells exhibited characteristics of a mature form of cathepsin B. Taken together, the cytochemical and biochemical data provide evidence that human breast epithelial cells of cancer origin, as well as in the transformed or growth-stimulated state express active cathepsin B and compartmentalize it into specific subcellular sites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667710     DOI: 10.1242/jcs.87.1.145

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

1.  Cathepsins D, B, and L in transformed human breast epithelial cells.

Authors:  T T Lah; G Calaf; E Kalman; B G Shinde; R Somers; S Estrada; E Salero; J Russo; I Daskal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

3.  Human tumour cathepsin B. Comparison with normal liver cathepsin B.

Authors:  K Moin; N A Day; M Sameni; S Hasnain; T Hirama; B F Sloane
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

4.  Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.

Authors:  S R Denmeade; W Lou; J Lövgren; J Malm; H Lilja; J T Isaacs
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

5.  Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; R Tateishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

6.  Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis.

Authors:  S Mahurkar; M M Idris; D N Reddy; S Bhaskar; G V Rao; V Thomas; L Singh; G R Chandak
Journal:  Gut       Date:  2006-02-21       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.